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Scleroderma, Stress and CAM Utilization
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Scleroderma is an autoimmune disease influenced by interplay among genetic and environ-
mental factors, of which one is stress. Complementary and alternative medicine (CAM) is
frequently used to treat stress and those diseases in which stress has been implicated. Results
are presented from a survey of patients with scleroderma. Respondents were a convenient
sample of those attending a national conference in Las Vegas in 2002. Findings implicate stress
in the onset, continuation and exacerbation of scleroderma. The implication is that CAM
providers may be filling an important patient need in their provision of services that identify
and treat stress and its related disorders.
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Introduction
Scleroderma, also known as systemic sclerosis (SSc), is an
autoimmune disease of unknown etiology characterized by
pronounced microvascular alterations, progressive fibrosis
and associated cellular and humoral immune abnormalities
(1). Clinically, scleroderma encompasses a spectrum of
disorders ranging from mild, limited forms of fibrosis of the
skin with minimal visceral involvement to severe skin and
multiple internal organ fibrosis involving the gastrointes-
tinal tract, lungs, heart and kidneys (1). Causes of
autoimmune diseases remain obscure (2).
It is argued that disease susceptibility, progression and
clinical presentation are influenced by a strong interplay
among genetic factors, lifecycle events, as well as natural
andsocialenvironmentaltriggers(3).Psychologicalstressis
thought to be associated with the onset and exacerbation of
these disorders, with recent scientific evidence suggesting a
relationship between stress-related brain disorders and
autoimmunity rooted in a common neuroendocrine defect
(2,4,5). In 2003, a study surveying a population of
individuals with SSc reported that more than 50% of
patients ascribed the cause of their condition to stress (6).
Despite increasing understanding of pathogenetic mecha-
nisms of immunologically and non-immunologically
induced fibrosis and the pathogenesis of scleroderma,
conventional therapy remainslargelyempirical withlimited
efficacy (7). One shortcoming may be that physicians are
not adequately identifying or treating stressors in the lives
oftheirpatients withscleroderma.Incontrast,patientsseek
out complementary and alternative medicine (CAM)
practitioners to identify and relieve those symptoms
commonly associated with stress, such as back pain, neck
pain, joint pain, anxiety and depression (8).
Drawing on knowledge gleaned from a search of the
literature and decades of clinical experience, we designed
an exploratory research project consisting of a survey
distributed to a convenience sample of patients with
scleroderma. We did not design the research to precisely
identify the etiology of scleroderma. Nor did we seek to
exhaustively catalogue the types of treatments that
patients receive for scleroderma. Our purpose was to
preliminarily examine two related hypotheses. The first
hypothesis is that psychosocial and mechanical stress
plays a role in the onset, continuation and exacerbation
of scleroderma. The second hypothesis is that, for the
sake of stress relief, people diagnosed with scleroderma
seek out CAM providers for treatment. Our argument
is that psychosocial and mechanical stress pervades the
For reprints and all correspondence: Ka-Kit Hui, MD, FACP,
Professor and Director,Center for East-West Medicine,Department
of Medicine, David Geffen School of Medicine at UCLA, 2428
Santa Monica Blvd., Suite 308,Santa Monica, CA 90404, USA.
Tel: 310-453-7679; Fax: 310-315-1856; E-mail: khui@mednet.ucla.edu
 2007 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original worki s
properly cited.entire process of system breakdown—manifesting in the
onset, continuation and exacerbation of scleroderma and
other diseases—and that because physicians do not fully
appreciate the importance of stress or provide therapeutic
services that relieve stress, patients are turning to CAM
providers. Figure 1 is a heuristic displaying the multi-
dimensional relation between baseline health, stress,
system breakdown and use of CAM.
Methods
At the Scleroderma Foundation’s 2002 National
Conference ‘Living Well with Scleroderma’ held in
Las Vegas on June 29–July 1, 2002, we collected
demographic, medical and health services utilization
information from a convenience sample of 113 individuals
diagnosed with scleroderma. To survey these people,
announcements were made at various sessions and surveys
were placed in a prominent place in the conference
registration for self-administration. According to Stacy
Wright, executive assistant to the CEO of the Scleroderma
Foundation, there were 520 attendees at the 2002
conference, of which she estimates that approximately
250 were people with scleroderma. Assuming that all were
notified of the survey, the response rate would be
approximately 45%. We have no systematic information
about the difference between those attendees with sclero-
derma who did and did not fill out the survey. Further,
we have no hard data about the difference between
scleroderma patients who do and do not attend this
conference. However, on the basis of extensive personal
experience with the annual conferences, Stacy Wright
notes that scleroderma attendees are extremely hetero-
geneous in multiple ways, including age of diagnosis, time
of diagnosis, disease progression and lifestyle. Though
diverse, generalizability is problematic. However, we do
not consider this to be a fatal flaw, because the purpose of
this preliminary research is to examine whether an insight
about stress is worthy of pursuing in future, more
rigorously developed research design.
Respondents were asked to identify physical, emotional
and environmental insults in their lives including past
surgical history, trauma/accident history, neck injuries,
neck tension and pain. They were also asked about
history of physical overexertion, recurrent infections,
Baseline Health
Respondents report:
￿ Family History of Immune-mediated 
  Problems (57%)
￿ Joint-pain Conditions (41%)
STRESS
Respondents report:
￿Prior Surgery (80%)
￿Increased Stress (72%)
￿Personal/Emotional Problems (50%)
￿Neck Tension/Pain (41%)
￿History of Anger/Anxiety (40%)
￿Serious Physical Trauma (26%)
￿Neck Injury (23%)
System Breakdown
(onset, continuation, or exacerbation of disease)
CAM
Respondents report:
￿Visited CAM practioner at least
 once in past year (59%)
CAM practioners visited:
￿Massage Therapist (40%)
￿Acupuncturist (16%)
￿Chiropractor (16%)
￿Nutritionist (15%)
￿Herbalist (6%)
￿Other CAM Practioner (21%)
Figure 1. Multidimensional relation between baseline health, stress, system breakdown, and CAM use.
504 Scleroderma, stress and CAM utilizationgynecologic disorders, other rheumatological diagnoses,
psychological and emotional problems, symptoms of cold
extremities and sensitivity to cold weather, as well as
family history of autoimmune disorders. There was not
sufficient time to secure validated scales from other
researchers or pretest the survey questions before the first
author attended the conference. Respondents were also
asked about their use of conventional medicine and CAM
services. The latter was operationalized in a series of six
questions that asked the respondent sequentially if they
had seen a massage therapist, a chiropractor, a herbalist,
an acupuncturist, a nutritionist, or any other provider of
complementary/alternative therapies in the last year.
Results
Gender and Age
Demographically, survey respondents were almost
entirely female (104 of 113). Of the female respondents,
28% had experienced endometriosis, breast pain and/or
pelvic pain before the onset of their scleroderma. The
average age of diagnosis for this group of patients with
scleroderma was 51 years.
Genetic Factors
Our results show that genetic factors are important in that
57% of respondents reported a family history of immune-
mediated problems such as allergies, eczema, or rheuma-
toid arthritis. Clinically, on average, respondents had been
diagnosed for scleroderma 18 years before attending the
2002 conference. A high percentage (41%), also reported
a history of other joint-pain conditions such as lupus,
fibromyalgia, rheumatoid arthritis. As expected, another
very common feature in our results is that virtually all
participants (98.2%) reported having cold hands or cold
feet and problems with cold weather. A high percentage
(41%) reported having a past medical history of recurrent
infections such as frequent flus, colds, urinary infections,
yeast infections, prior to disease onset.
Possible Role of Stress
In line with our hypothesis that stress plays a role in the
onset, continuation and exacerbation of scleroderma, we
find psychosocial and mechanical stress to be very
prevalent in this sample. Psychologically, 72% of the
respondents self-report increased stress, 50% personal/
emotional problems and 40% a history of anger and
anxiety before onset of scleroderma. Physically, 23% had
engaged in some intense physical exercise such as weight
training before the onset of scleroderma, 80% of indi-
viduals had undergone some kind of surgery, 41% had a
history of neck tension and pain, 23% of respondents
reported having injured their neck, 26% had experienced
serious physical trauma such as that which would result
from a car accident.
Prior Treatment by CAM Practitioners
Regarding our hypothesis that people diagnosed with
scleroderma seek out CAM providers, we find that 67 of
the 113 respondents (59%) reported seeing at least one
CAM practitioners in the past year. Among these, 27
indicated seeing a massage therapist, 11 an acupuncturist,
11a chiropractor, 10a nutritionist, 4a herbalist and 14
another kind of CAM provider. Among those who had
seen a CAM practitioner, 41 (61%) reported that their
medical doctor knew they were seeing a complementary/
alternative practitioner. When the medical doctor was
aware, in only 24% of the cases (10/41), did they discuss
with the patient how complications may arise due to an
interaction between the CAM and conventional treatment
and in only 7% of the cases (3/41) did the medical doctor
discuss potential complications with the patient’s CAM
practitioner. Among our respondents, only four respon-
dents reported seeing a herbalist, of which three had
discussed with their doctors about possible complications
and in one case the physician had spoken directly with
the herbalist.
Discussion
Our preliminary results provide a warrant for more careful
investigation of the hypothesis that stress, whether result-
ing from psychological, mechanical overloading and/or
injury, including surgery or accidents, may activate or
exacerbate the pathogenetic processes in patients with
scleroderma. Our findings resonate with general and
specific theories in the literature. Both physiologic function
and health outcomes have been shown to be directly
influenced by psychosocial factors from emotional states,
behavioral dispositions and psychosocial stress (9). In a
study of women with Sjogren’s syndrome, which is
commonly associated with scleroderma, authors reported
that a majority of participants considered their experience
of a stressful life event 6 months–2 years before the onset of
their symptoms to be highly significant (5).
We do not see our preliminary findings as contradicting
arguments about the importance of genetic factors in
scleroderma. Genes, one’s experiences, lifestyle and
stressful life experiences all help determine allostatic
load, which is equivalent to the cost to a person’s body to
adapt to a changing environment (10). Accumulation
of allostatic load with attendant overexposure to neu-
roendocrine and immune stress mediators can impair
various organ functions, leading to disease (10).
We emphasize that a sizable number of people in this
convenience sample perceived themselves to be suffering
from stress of a mechanical nature, stress that results
from physical overexertion, surgery, accidents, or inter-
current infections. Additionally, our survey shows that
many patients perceived themselves to experience an
increase in personal/emotional problems prior to the
eCAM 2009;6(4) 505onset of scleroderma. Astin and colleagues (9) point out
that in spite of the biopsychosocial model and consider-
able evidence of efficacy for several mind–body therapies
in stress-induced diseases, psychosocial factors continue
to be underappreciated in many clinical encounters. In
this article, we expand the psychosocial conceptualization
of stress to include mechanical stress, which has the
further implication that stress management is not limited
to body–mind interventions; physical interventions such
as massage and acupuncture can also play a role in stress
reduction.
Our data also suggest that people diagnosed with
scleroderma seek out CAM providers for assistance in
relieving symptoms and conditions commonly associated
with stress. Among the respondents in this sample, nearly
60% used CAM services. This also resonates with
existing literature in that a high percentage of patients
with rheumatologic disease conditions use CAM (11–14).
Only 24% of those respondents who had notified their
physicians that they were seeing a CAM provider had
discussed possible complications with their physician.
However, amongst those seeing a herbalist, 75% had
communicated with their physician about possible com-
plications. We agree that susceptibility, progression and
clinical presentation of scleroderma are influenced by a
strong interplay of several factors, of which one is psy-
chosocial stress (2–5). Our preliminary findings further
suggest that mechanical stress is involved in the onset,
continuation and exacerbation of scleroderma. In that
they provide services which identify and treat stress,
CAM providers may be playing an important role in the
management of scleroderma.
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